InsiderClue
← All stocks

Immunome Inc.

IMNM Net buying
CIK 0001472012 #1696 in the set updated 17 Sep 2026
Bought (120 mo)
$12.77M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$27.79M
$18.48M on a plan · $7.77M straight out of an exercise
Sold at will
$1.54M
4 of 30 sales
Net
−$15.02M
+$11.23M against sales at will

By person

19 insiders · 75 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Barchas Isaac
Director
—
$18.27M (12) scheduled
−$18.27M
92,211
0.0812%
$2.33M
−89.7%
SIEGALL CLAY B
President and CEO
$7.26M (11)
—
+$7.26M
870,704
0.7666%
$22.05M
+478.8%
RAPP MICHAEL
Director
$3.33M (8)
—
+$3.33M
1,416,744
1.25%
$35.87M
+271.7%
Rosett Max
Chief Financial Officer
—
$2.75M (4) scheduled
−$2.75M
101,287
0.0892%
$2.56M
+410.1%
Horn Kinney
CHIEF BUSINESS OFFICER
—
$2.30M (2) scheduled
−$2.30M
0
0.0000%
$0.00
—
Lechleider Robert
Chief Medical Officer
$149.80K (1)
$2.34M (5) scheduled
−$2.19M
69,805
0.0615%
$1.77M
—
WAGENHEIM PHILIP
Director
$247.73K (1)
$1.34M (2)
−$1.09M
341,147
0.3004%
$8.64M
−11.1%
Higgins Jack
Chief Scientific Officer
—
$587.53K (3) scheduled
−$587.53K
60,250
0.0530%
$1.53M
+5,925%
Tsai Philip
Chief Technical Officer
$506.50K (3)
—
+$506.50K
81,550
0.0718%
$2.06M
—
BIENAIME JEAN JACQUES
Director
$641.23K (11)
$203.82K (2)
+$437.41K
43,415
0.0382%
$1.10M
+470.1%
Turner Bruce
Chief Strategy Officer
$249.99K (1)
—
+$249.99K
42,300
0.0372%
$1.07M
—
Sarma Purnanand D
President and CEO
$193.31K (1)
—
+$193.31K
10,500
0.0092%
$265.86K
—
LAMATTINA JOHN L
Director
$101.03K (2)
—
+$101.03K
66,953
0.0589%
$1.70M
—
Lefenfeld Michael
Director
$86.15K (3)
—
+$86.15K
40,747
0.0359%
$1.03M
—
MORRIS I WISTAR III
10% owner
—
—
—
920,939
0.8108%
$23.32M
—
PRENDERGAST FRANKLYN G
Director
—
—
—
60,840
0.0536%
$1.54M
—
Widlitz Michael
Director
—
—
—
51,315
0.0452%
$1.30M
—
Stoneman Sandra G.
CHIEF LEGAL OFFICER & GC
—
—
—
43,805
0.0386%
$1.11M
+688.6%
BARON RICHARD A
Director
—
—
—
2,343
0.0021%
$59.32K
—

Individual transactions

75
Insider
Date
Role
Action
Shares
Price
Amount
Higgins Jack
11 Sep 2026
Chief Scientific Officer
Sold after exercise
13,200
$25.32
$334.22K
Barchas Isaac
12 Aug 2026
Director
Sold on a plan
11,048
$27.25
$301.06K
Barchas Isaac
11 Aug 2026
Director
Sold on a plan indirect
62,291
$26.23
$1.63M
Barchas Isaac
10 Aug 2026
Director
Sold on a plan indirect
10,125
$26.07
$263.96K
Barchas Isaac
7 Aug 2026
Director
Sold on a plan indirect
15,248
$26.06
$397.36K
Barchas Isaac
6 Aug 2026
Director
Sold on a plan indirect
20,840
$26.06
$543.09K
Horn Kinney
4 Aug 2026
CHIEF BUSINESS OFFICER
Sold after exercise
90,616
$25.09
$2.27M
Barchas Isaac
7 Jul 2026
Director
Sold on a plan indirect
16,906
$24.20
$409.13K
Horn Kinney
7 Jul 2026
CHIEF BUSINESS OFFICER
Sold after exercise
1,092
$25.00
$27.30K
Barchas Isaac
6 Jul 2026
Director
Sold on a plan indirect
83,094
$24.11
$2.00M
Barchas Isaac
2 Jul 2026
Director
Sold on a plan indirect
24,335
$23.33
$567.74K
Barchas Isaac
2 Jul 2026
Director
Sold on a plan indirect
75,665
$22.35
$1.69M
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,072
$23.44
$376.73K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
16,214
$22.76
$369.03K
Lechleider Robert
2 Jul 2026
Chief Medical Officer
Sold after exercise
22,714
$21.95
$498.57K
Barchas Isaac
30 Jun 2026
Director
Sold on a plan indirect
101,050
$21.12
$2.13M
Lechleider Robert
25 Jun 2026
Chief Medical Officer
Sold after exercise
14,420
$20.66
$297.92K
Lechleider Robert
25 Jun 2026
Chief Medical Officer
Sold after exercise
40,580
$19.56
$793.74K
Rosett Max
15 Jun 2026
Chief Financial Officer
Sold after exercise
60,000
$18.23
$1.09M
BIENAIME JEAN JACQUES
5 Jun 2026
Director
Buy
1,000
$19.27
$19.27K
BIENAIME JEAN JACQUES
5 Jun 2026
Director
Buy
3,500
$19.46
$68.11K
BIENAIME JEAN JACQUES
5 Jun 2026
Director
Buy
6,000
$19.48
$116.88K
BIENAIME JEAN JACQUES
5 Jun 2026
Director
Sell
10,000
$19.41
$194.10K
BIENAIME JEAN JACQUES
5 Jun 2026
Director
Sell
500
$19.44
$9.72K
BIENAIME JEAN JACQUES
15 May 2026
Director
Buy
5,000
$20.70
$103.50K
Rosett Max
2 Apr 2026
Chief Financial Officer
Sold after exercise
1,344
$22.48
$30.21K
Rosett Max
2 Apr 2026
Chief Financial Officer
Sold after exercise
63,656
$21.91
$1.39M
Higgins Jack
2 Apr 2026
Chief Scientific Officer
Sold on a plan
9,438
$21.64
$204.24K
SIEGALL CLAY B
27 Mar 2026
President and CEO
Buy
25,450
$19.67
$500.60K
WAGENHEIM PHILIP
23 Mar 2026
Director
Sell
28,200
$20.65
$582.33K
WAGENHEIM PHILIP
20 Mar 2026
Director
Sell
36,800
$20.47
$753.30K
BIENAIME JEAN JACQUES
11 Mar 2026
Director
Buy
1,000
$21.55
$21.55K
BIENAIME JEAN JACQUES
10 Mar 2026
Director
Buy
1,000
$22.12
$22.12K
SIEGALL CLAY B
30 Dec 2025
President and CEO
Buy
4,729
$21.15
$100.02K
Barchas Isaac
22 Dec 2025
Director
Sold on a plan indirect
11,251
$22.34
$251.35K
Barchas Isaac
22 Dec 2025
Director
Sold on a plan indirect
371,949
$21.72
$8.08M
Tsai Philip
19 Dec 2025
Chief Technical Officer
Buy
10,000
$20.49
$204.90K
SIEGALL CLAY B
19 Dec 2025
President and CEO
Buy
7,278
$20.48
$149.05K
SIEGALL CLAY B
18 Dec 2025
President and CEO
Buy
46,511
$21.50
$999.99K
Higgins Jack
10 Sep 2025
Chief Scientific Officer
Exercised, kept
22,000
$1.35
$29.70K
BIENAIME JEAN JACQUES
3 Jun 2025
Director
Buy
5,000
$9.38
$46.90K
Higgins Jack
27 Mar 2025
Chief Scientific Officer
Exercised, kept
5,200
$1.35
$7.02K
SIEGALL CLAY B
26 Mar 2025
President and CEO
Buy
137,100
$7.29
$999.46K
BIENAIME JEAN JACQUES
25 Mar 2025
Director
Buy
7,800
$7.78
$60.68K
Tsai Philip
24 Mar 2025
Chief Technology Officer
Buy
12,300
$8.42
$103.57K
BIENAIME JEAN JACQUES
24 Mar 2025
Director
Buy
7,000
$8.21
$57.47K
SIEGALL CLAY B
31 Jan 2025
President and CEO
Buy
150,000
$7.75
$1.16M
SIEGALL CLAY B
22 Nov 2024
President and CEO
Buy
33,943
$9.78
$331.92K
Tsai Philip
21 Nov 2024
Chief Technology Officer
Buy
21,000
$9.43
$198.03K
Lechleider Robert
21 Nov 2024
Chief Medical Officer
Buy
15,805
$9.48
$149.80K
SIEGALL CLAY B
21 Nov 2024
President and CEO
Buy
66,057
$9.54
$630.26K
Rosett Max
19 Sep 2024
Chief Financial Officer
Sold after exercise
14,380
$16.01
$230.22K
BIENAIME JEAN JACQUES
16 Aug 2024
Director
Buy
7,000
$13.94
$97.61K
Higgins Jack
15 Aug 2024
Chief Scientific Officer
Sold after exercise
3,524
$13.93
$49.07K
SIEGALL CLAY B
21 May 2024
President and CEO
Buy
20,434
$13.78
$281.55K
BIENAIME JEAN JACQUES
21 May 2024
Director
Buy
2,000
$13.57
$27.14K
SIEGALL CLAY B
20 May 2024
President and CEO
Buy
79,566
$13.91
$1.11M
Turner Bruce
2 Oct 2023
Chief Strategy Officer
Buy
42,300
$5.91
$249.99K
SIEGALL CLAY B
2 Oct 2023
President and CEO
Buy
169,204
$5.91
$1,000.00K
RAPP MICHAEL
13 Sep 2021
Director
Buy indirect
25,962
$19.96
$518.20K
RAPP MICHAEL
10 Sep 2021
Director
Buy indirect
15,500
$17.85
$276.68K
RAPP MICHAEL
9 Sep 2021
Director
Buy indirect
22,280
$18.46
$411.29K
RAPP MICHAEL
9 Sep 2021
Director
Buy indirect
8,170
$17.44
$142.48K
BARON RICHARD A
18 Aug 2021
Director
Exercised, kept
2,343
$11.38
$26.66K
RAPP MICHAEL
26 May 2021
Director
Buy indirect
2,300
$18.94
$43.56K
Lefenfeld Michael
26 May 2021
Director
Buy
1,335
$19.03
$25.41K
Sarma Purnanand D
25 May 2021
President and CEO
Buy
10,500
$18.41
$193.31K
RAPP MICHAEL
25 May 2021
Director
Buy indirect
19,303
$18.32
$353.63K
Lefenfeld Michael
25 May 2021
Director
Buy
2,715
$18.44
$50.06K
LAMATTINA JOHN L
24 May 2021
Director
Buy
5,102
$18.58
$94.80K
LAMATTINA JOHN L
24 May 2021
Director
Buy
338
$18.44
$6.23K
WAGENHEIM PHILIP
24 May 2021
Director
Buy
13,500
$18.35
$247.73K
RAPP MICHAEL
24 May 2021
Director
Buy indirect
31,895
$18.38
$586.23K
Lefenfeld Michael
24 May 2021
Director
Buy
600
$17.80
$10.68K
RAPP MICHAEL
6 Oct 2020
Director
Buy
83,332
$12.00
$999.98K

What was left out

Form 4 filings counted 156
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 13
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 3,059,462
History held since 5 Oct 2020